Status:
COMPLETED
A Study to Evaluate Unintended Prolonged Opioid Use
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Center for Advancing Translational Sciences (NCATS)
Conditions:
Opioid Use
Eligibility:
All Genders
18+ years
Brief Summary
Researchers are trying to better understand how people who are prescribed opioids for short-term use, go on to receive this type of medication on a longer-term basis.
Detailed Description
Identify incident cases of UPOU and prospectively assess their characteristics in comparison to new opioid users who do not progress to UPOU. At each site, opioid-naïve adults who receive opioid presc...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- No use of opioids for 6 months prior to the issuance of the initial opioid prescription
- Willingness to participate in all aspects of the study including use of the Hugo platform on their personal smartphone
Exclusion
- Cancer-associated pain
- Concurrent treatment for cancer (e.g., chemotherapy, radiation therapy)
- Residence in an extended care facility
- Any operation or hospitalization within the past 6 months
- Mental health disorders that could impede functioning in an ambulatory care setting (e.g., schizophrenia, dementia)
- Non-English speaking individuals
- No smartphone
- Use of a pharmacy that is not compatible with the Hugo platform.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 29 2023
Estimated Enrollment :
1796 Patients enrolled
Trial Details
Trial ID
NCT04024397
Start Date
October 1 2019
End Date
December 29 2023
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905